TY  - JOUR
AU  - Lopez-Pedrera, Chary
AU  - Barbarroja, Nuria
AU  - Jimenez-Gomez, Yolanda
AU  - Collantes-Estevez, Eduardo
AU  - Aguirre, Ma Angeles
AU  - Cuadrado, Ma Jose
PY  - 2016
DO  - 10.1093/rheumatology/kew054
UR  - http://hdl.handle.net/10668/9947
T2  - Rheumatology (Oxford, England)
AB  - Atherothrombosis is a recurrent complication in APS and SLE patients. Oxidative stress has been suggested as a key player underlying this process. Autoantibodies have been pointed to as the main contributors to abnormality in the oxidative status...
LA  - en
PB  - Oxford University Press
KW  - anti-phospholipid syndrome
KW  - atherothrombosis
KW  - oxidative stress
KW  - systemic lupus erythematosus
KW  - therapeutic approaches
KW  - Acetylcysteine
KW  - Anticoagulants
KW  - Antioxidants
KW  - Antiphospholipid Syndrome
KW  - Atherosclerosis
KW  - Autoantibodies
KW  - Coagulants
KW  - Humans
KW  - Hydroxymethylglutaryl-CoA Reductase Inhibitors
KW  - Inflammation
KW  - Lupus Erythematosus, Systemic
KW  - Mitochondrial Diseases
KW  - Oxidative Stress
KW  - Reactive Oxygen Species
KW  - Recurrence
KW  - Thrombosis
KW  - Ubiquinone
KW  - beta 2-Glycoprotein I
TI  - Oxidative stress in the pathogenesis of atherothrombosis associated with anti-phospholipid syndrome and systemic lupus erythematosus: new therapeutic approaches.
TY  - research article
VL  - 55
ER  -